Cathay Pacific Haitong Securities Co., Ltd. summary report on the initial public offering of shares and continued supervision and sponsorship of Hangzhou Botuo Biotechnology Co., Ltd. and its listing on the Science and Technology Innovation Board
Botuo Biotech\'s announcement on the 2024 annual profit distribution and capital reserve transfer plan to increase share capital
Botuo Biotech: Botuo Biotech\'s directors and senior management announced plans to reduce their shareholding
Botuo Biotech Director and Senior Management Announces Plan to Reduce Shareholding
Botuo Biotech\'s equity distribution implementation announcement for the first three quarters of 2024
Botuo Biotech\'s announcement on adjusting the profit distribution plan for the first three quarters of 2024
Botuo Biotech: Botuo Biotech\'s announcement on the completion of the 2024 Employee Stock Ownership Plan non-transactional transfer
Botuo Biotech\'s announcement on the profit distribution plan for the first three quarters of 2024
Botuo Biotech\'s initial public offering of some restricted shares
Announcement of the results of BoTai Biology's repurchase of company shares through centralized bidding trading, reaching 2% of the total share capital.
Announcement on the progress of Botai Biotechnology's repurchase of company shares by means of centralized bidding trade.
Announcement regarding the adjustment of the repurchase share price limit after the implementation of the annual equity distribution of Biotop in 2023.
Botuo Biotech's 2023 Annual Equity Distribution Implementation Notice
Botuo Biotech's progress announcement on the repurchase of the company's shares through centralized bidding
Botuo Biotech's progress announcement on the repurchase of the company's shares through centralized bidding
Botuo Biotech's Corrective Notice on the “Notice Concerning the 2023 Profit Distribution Plan”
Botuo Biotech's announcement on the 2023 profit distribution plan
Botuo Biotech's progress announcement on the repurchase of the company's shares through centralized bidding
Botuo Biotech's progress announcement on the repurchase of the company's shares through centralized bidding
Botuo Biotech announced that the share repurchase ratio of the company reached 1% of the total share capital through centralized bidding transactions and the progress of the repurchase